These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6308362)

  • 1. Lack of correlation between serum angiotensin-converting enzyme levels and asbestosis in man, sheep and guinea-pig.
    Forget G; Brault C; Cadieux A; Bégin R; Sirois P
    Lung; 1983; 161(3):157-64. PubMed ID: 6308362
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetic and inhibitory characteristics of serum angiotensin-converting enzyme from nine mammalian species.
    Ibarra-Rubio ME; Pena JC; Pedraza-Chaverri J
    Comp Biochem Physiol B; 1989; 92(2):399-403. PubMed ID: 2538295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum angiotensin-converting enzyme and lysosomal enzymes in asbestosis.
    Huuskonen MS; Jävisalo J; Koskinen H; Kivistö H
    Lung; 1986; 164(3):165-71. PubMed ID: 3014231
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin-converting enzyme and lysozyme in silicosis and asbestosis.
    Grönhagen-Riska C; Kurppa K; Fyhrquist F; Selroos O
    Scand J Respir Dis; 1978 Aug; 59(4):228-31. PubMed ID: 211579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors.
    Subissi A; Criscuoli M; Sardelli G; Guelfi M; Giachetti A
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):139-46. PubMed ID: 1383623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
    Udupa EG; Rao NM
    Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Captopril caused a far lesser reduction in serum angiotensin-converting enzyme (ACE).
    Pedersen HD; Koch J
    J Vet Intern Med; 1999; 13(1):76-7. PubMed ID: 10052068
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of captopril on angiotensin-converting enzyme activity and animal behavior in the "open field" test].
    Vernigora AN; Gengin MT; Nikishin NN; Shchetinina NV
    Vopr Med Khim; 1996; 42(1):34-8. PubMed ID: 8999656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The measurement of angiotensin-converting enzyme in subjects receiving captopril.
    Roulston JE; MacGregor GA
    N Engl J Med; 1980 Aug; 303(7):397. PubMed ID: 6248782
    [No Abstract]   [Full Text] [Related]  

  • 10. The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril.
    Essig J; Belz GG; Wellstein A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):217S-223S. PubMed ID: 2548551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chloride and diamide on serum angiotensin I-converting enzyme activity from eight mammalian species.
    Ibarra-Rubio ME; Gómez-Velez LA; Cruz C; Pedraza-Chaverrí J
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1993 Oct; 106(2):495-501. PubMed ID: 7904922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antienzymic activity of two new angiotensin converting enzyme inhibitors.
    Dudkiewicz J; Suska T; Tautt J; Paruszewski R
    Pol J Pharmacol Pharm; 1991; 43(1):33-8. PubMed ID: 1663247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide donors and angiotensin-converting enzyme inhibitors act in concert to inhibit human angiotensin-converting enzyme activity and platelet aggregation in vitro.
    Persson K; Whiss PA; Nyhlén K; Jacobsson-Strier M; Glindell M; Andersson RG
    Eur J Pharmacol; 2000 Oct; 406(1):15-23. PubMed ID: 11011027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effects of captopril on angiotensin I-converting enzyme 'activity' and 'concentration'; relation between enzyme inhibition and long-term blood pressure response.
    Boomsma F; de Bruyn JH; Derkx FH; Schalekamp MA
    Clin Sci (Lond); 1981 May; 60(5):491-8. PubMed ID: 6265138
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical and immunological studies of angiotensin converting enzymes from human, bovine, dog, hog, rabbit, rat and sheep kidneys.
    Takada Y; Unno M; Hiwada K; Kokubu T
    Comp Biochem Physiol B; 1982; 73(2):189-94. PubMed ID: 6293756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of angiotensin-converting enzyme without kininase activity from hog and guinea pig plasma.
    Grandino A; Paiva AC
    Biochim Biophys Acta; 1974 Sep; 364(1):113-9. PubMed ID: 4373067
    [No Abstract]   [Full Text] [Related]  

  • 17. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
    Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
    Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
    Kaplan HR; Cohen DM; Essenburg AD; Major TC; Mertz TE; Ryan MJ
    Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species differences in the angiotensin converting enzyme activity of mammalian serum.
    Kase R; Hazato T; Kiuchi Y; Katayama T
    Jikken Dobutsu; 1986 Jan; 35(1):107-8. PubMed ID: 3011465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the time interval between blood sampling and assay on serum angiotensin I-converting enzyme activity from captopril-treated rats.
    Lai FM; Tanikella T; Herzlinger H; Cervoni P
    Eur J Pharmacol; 1980 Oct; 67(1):97-9. PubMed ID: 6252028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.